The Basics difference between Gem/Cis with Durvalumab vs. Keytruda By Steve|2024-10-11T16:07:49+10:00November 18th, 2023|Categories: All, Updates, Z-Legacy|Tags: immunotherapy| Read More 2
Merck’s Keytruda: A New Hope in Biliary Tract Cancer By Steve|2024-10-11T16:07:51+10:00November 5th, 2023|Categories: All, Z-Legacy|Tags: durvalumab, Infinzi, Keytruda| Read More 0
PBAC Recommends IMFINZI (durvalumab) for Cholangiocarcinoma Patients in Australia By Steve|2024-10-11T16:07:53+10:00August 29th, 2023|Categories: All, Media, Updates, Z-Legacy|Tags: durvalumab| Read More 0
Testimonials By Steve|2024-10-11T16:07:54+10:00August 4th, 2023|Categories: All, Z-Legacy| Read More 0
Steven West: Cholangio Survivor By Steve|2024-10-11T16:07:55+10:00August 2nd, 2023|Categories: All, Testimonials, Z-Legacy|Tags: Testimonials| Read More 0
Lynette Williams: Cholangiocarcinoma Survivor By Steve|2026-01-13T13:49:36+10:00July 31st, 2023|Categories: All, Testimonials, Z-Legacy|Tags: Testimonials| Read More 0
Lisa Salem-Craine: Cholangio Survivor By Steve|2024-10-11T16:08:02+10:00July 25th, 2023|Categories: All, Testimonials, Z-Legacy|Tags: Testimonials, USA| Read More 0
Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer By Steve|2024-10-11T16:08:05+10:00December 2nd, 2022|Categories: Publication, Z-Legacy|Tags: Clinical Trial, durvalumab, Topaz| Read More 0
Lisa Craine By Steve|2024-10-11T16:08:05+10:00August 15th, 2022|Categories: All, PATIENT, Z-Legacy|Tags: Patient Success| Read More 1
Melinda Bachini By Steve|2024-11-03T15:37:25+10:00August 15th, 2022|Categories: All, PATIENT, Z-Legacy|Tags: adoptive Cell Therapy, Intrahepatic, Keytruda, patient, Trial Patient, USA, Videos-Immuno, Videos-Patients| Read More 2